Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CRMD – CorMedix Inc.

CorMedix Inc.
CRMD
$9.98
Name : CorMedix Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $786,314,688.00
EPSttm : 2.21
finviz dynamic chart for CRMD
CorMedix Inc.
$9.98
11.21%
$1.26

Float Short %

22.92

Margin Of Safety %

49

Put/Call OI Ratio

0.38

EPS Next Q Diff

EPS Last/This Y

2.35

EPS This/Next Y

0.38

Price

9.97

Target Price

19

Analyst Recom

1

Performance Q

-23.58

Relative Volume

1.67

Beta

1.31

Ticker: CRMD




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-20CRMD12.160.390.4448028
2025-10-21CRMD11.650.410.0653270
2025-10-22CRMD11.210.390.7055300
2025-10-23CRMD11.310.390.1856388
2025-10-24CRMD11.160.390.2257512
2025-10-27CRMD11.050.390.1158295
2025-10-28CRMD11.130.380.2459880
2025-10-29CRMD11.30.370.0760971
2025-10-30CRMD11.610.370.1861458
2025-10-31CRMD11.120.370.3162386
2025-11-03CRMD11.540.380.2062840
2025-11-04CRMD11.410.380.0263109
2025-11-05CRMD11.160.380.1363082
2025-11-06CRMD10.760.390.1962699
2025-11-07CRMD10.780.380.0663425
2025-11-10CRMD11.070.380.1863906
2025-11-11CRMD11.190.380.3765062
2025-11-12CRMD11.430.380.1966357
2025-11-13CRMD11.220.380.1566814
2025-11-14CRMD11.230.380.3766603
2025-11-17CRMD9.980.380.3266383
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-20CRMD12.16974.3- 1.79
2025-10-21CRMD11.65974.3- 1.79
2025-10-22CRMD11.20974.3- 1.74
2025-10-23CRMD11.30974.3- 1.74
2025-10-24CRMD11.151368.6- 2.08
2025-10-27CRMD11.061368.6- 2.08
2025-10-28CRMD11.141368.6- 2.08
2025-10-29CRMD11.311368.6- 2.08
2025-10-30CRMD11.621368.6- 2.08
2025-10-31CRMD11.131368.6- 2.08
2025-11-03CRMD11.531368.6- 2.08
2025-11-04CRMD11.401368.6- 2.08
2025-11-05CRMD11.161368.6- 2.08
2025-11-06CRMD10.761368.6- 2.08
2025-11-07CRMD10.761368.6- 2.08
2025-11-10CRMD11.081368.6- 2.08
2025-11-11CRMD11.191368.6- 2.08
2025-11-12CRMD11.441368.6- 2.08
2025-11-13CRMD11.221368.6- 2.08
2025-11-14CRMD11.25270.0- 2.05
2025-11-17CRMD9.97270.0- 2.05
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-20CRMD-1.9818.8822.17
2025-10-21CRMD-1.9818.8822.17
2025-10-22CRMD-1.9818.8822.17
2025-10-23CRMD-1.9818.8822.17
2025-10-24CRMD-1.9818.8822.17
2025-10-27CRMD-1.9818.9123.05
2025-10-28CRMD-1.6818.9123.05
2025-10-29CRMD-1.6718.9123.06
2025-10-30CRMD-1.6718.9123.06
2025-10-31CRMD-1.6718.9123.06
2025-11-03CRMD-1.6718.2223.06
2025-11-04CRMD-1.6718.2223.06
2025-11-05CRMD-1.6718.2223.06
2025-11-06CRMD-1.6718.2223.06
2025-11-07CRMD-1.6718.2223.06
2025-11-10CRMD-1.6718.0023.06
2025-11-11CRMD-1.6718.0023.06
2025-11-12CRMD-1.6718.0023.66
2025-11-13CRMD-1.6718.0023.66
2025-11-14CRMD-1.6718.0023.05
2025-11-17CRMD-2.1319.5122.92
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.57

Avg. EPS Est. Current Quarter

0.81

Avg. EPS Est. Next Quarter

Insider Transactions

-2.13

Institutional Transactions

19.51

Beta

1.31

Average Sales Estimate Current Quarter

127

Average Sales Estimate Next Quarter

127

Fair Value

14.84

Quality Score

99

Growth Score

63

Sentiment Score

92

Actual DrawDown %

47

Max Drawdown 5-Year %

-84.5

Target Price

19

P/E

4.86

Forward P/E

4.04

PEG

P/S

3.67

P/B

2.09

P/Free Cash Flow

10.57

EPS

2.05

Average EPS Est. Cur. Y​

2.05

EPS Next Y. (Est.)

2.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

75.83

Relative Volume

1.67

Return on Equity vs Sector %

16.5

Return on Equity vs Industry %

31.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.26

EBIT Estimation

CorMedix Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 64
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
stock quote shares CRMD – CorMedix Inc. Stock Price stock today
news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRMD – CorMedix Inc. yahoo finance google finance
stock history CRMD – CorMedix Inc. invest stock market
stock prices CRMD premarket after hours
ticker CRMD fair value insiders trading